Data correlating b-lactamases found in commensal Escherichia coli of human and animal origin are limited. In this study, 447 commensal E. coli isolates from the faeces of humans and swine (280 human isolates from four hospitals and 167 swine isolates from seven farms) were collected between September 2006 and January 2009 in western China. For extended-spectrum b-lactamase (ESBL)-producing and other cephalosporin-resistant isolates, the relevant b-lactamase genes (bla TEM , bla SHV , bla CTX-M-1/2/9 group, bla CMY-2 and bla KPC ) were detected by PCR analysis. Of the 447 isolates tested, 120 (26.8 %) were confirmed as producing ESBL. Among these, 70 and 40 human isolates carried a member of the bla CTX-M-1 group (13 bla CTX-M-3 , 21 bla CTX-M-15 , four bla CTX-M-22 , eight bla CTX-M-28 , four bla CTX-M-36 , 15 bla CTX-M-55 and five bla CTX-M-69 ) or bla SHV (14 bla SHV-2 , seven bla SHV-5 , ten bla SHV-12 , five bla SHV-57 and four bla SHV-97 ), respectively, whilst six and four swine isolates carried a member of the bla CTX-M-1 group (one bla CTX-M-15 and five bla CTX-M-22 ) or bla SHV (three bla SHV-2 and one bla SHV-12 ), respectively. Furthermore, 59 human and swine isolates and seven human isolates carried bla CMY-2 and bla KPC , respectively. These findings indicate that the bla CTX-M-1 group, including the novel variant bla CTX-M-69 , and bla SHV are the predominant ESBL genes in both humans and swine in western China, and bla CMY-2 is also common in both groups. The carriage rates of broad-spectrum b-lactamases among commensal E. coli was much lower in swine than in humans, suggesting that b-lactamase genes have not established themselves in animal ecosystems in western China.
INTRODUCTION
Escherichia coli is part of the human and animal intestinal flora and is a major cause of infections such as urinary tract infection and bacteraemia. Commensal E. coli strains may serve as a reservoir for transmissible antimicrobial resistance to other E. coli strains that cause extra-intestinal infections or other virulent species (Gennis & Stewart, 1996) .
b-Lactams are among the critically important antimicrobials in both human and veterinary medicine. The predominant mechanism of resistance to b-lactams in E. coli is production of b-lactamase. With the increasing use of b-lactams in animals over the last several decades, it is not surprising that some commensal organisms in animals have acquired b-lactamase genes . A substantial increase in the rate of b-lactamases including CTX-M-type, SHV-2 and CMY-2 has been observed in swine in China over the last few years (Liu et al., 2007; Ma et al., 2009; Yuan et al., 2009 ).
Production of extended-spectrum b-lactamases (ESBLs) reduces the efficacy of expanded-spectrum cephalosporins and therefore ESBLs are among the most important acquired resistance determinants emerging worldwide in E. coli (Bradford, 2001; Paterson & Bonomo, 2005) . CMYtype b-lactamases, whilst less common than ESBLs, have a IP: 54.70.40.11
On: Sat, 13 Apr 2019 19:33:46 spectrum similar to that of ESBLs and also render E. coli resistant to most cephalosporins (Philippon et al., 2002) . KPC-type b-lactamases confer resistance to carbapenems and have become increasingly prevalent in many countries, including China .
Furthermore, b-lactamase-producing isolates represent an emerging clinical threat, not only because they are disseminated quickly, but also because their presence in bacteria has been associated with resistance to other classes of non-b-lactam antibiotics including fluoroquinolones, aminoglycosides and gentamicin (Schwaber et al., 2005) . These antimicrobials are often used long term to treat and prevent diseases on pig farms in China (Liu et al., 2007; Tian et al., 2009; Yuan et al., 2009; Zhou et al., 2000) .
Studies focusing on the characterization of these clinically important b-lactamases in extra-intestinal E. coli isolates of human and animal origin have been performed worldwide (Bradford, 2001; Li et al., 2007) . However, few studies have been conducted with commensal E. coli isolates of other origins such as healthy animals (Hunter et al., 1993; Sunde & Sørum, 1999) or humans (Gulay et al., 2000; Shanahan et al., 1995) , which may play an important role in the ecology of resistance and may be a culprit for subsequent infections. The objective of this study was to investigate the b-lactamases present among cephalosporin-resistant commensal E. coli isolates recovered from the faeces of healthy humans and swine in western China.
METHODS
Bacterial strains and plasmids. The strains and plasmids used in this study are shown in Table 1 . The E. coli isolates investigated in this study were collected from human faecal samples from four hospitals (223 healthy human volunteers and 57 patients) and swine faecal samples from seven farms (167 animals) between September 2006 and January 2009 in western China. The volunteers who participated had not been treated with antibiotics for at least 3 months preceding the isolation of E. coli. The E. coli isolates from patients were not implicated in any infection and were not treated with antimicrobials, and thus could be considered part of the microflora at the time in these individuals (Briñas et al., 2002) . Colonies consistent with E. coli were identified on MacConkey agar plates (Oxoid). Putative E. coli isolates were then identified biochemically using an API 20E system (bioMérieux). Only one isolate was included from each subject. The study was approved by the local ethics board, and consent was obtained from all patients and volunteers. E. coli DH5a was used as the host in conjugation experiments. E. coli BL21(DE3) was used as the recipient to transform recombinant plasmids and also as the host for cloning experiments. pET30b(+) with a kanamycin-resistance determinant was used as the cloning vector.
Antibiotic susceptibility testing. Susceptibility to ampicillin, cefoxitin, ceftazidime, ceftriaxone, cefotaxime, ceftiofur, imipenem, aztreonam, cefepime, cefpodoxime, tetracycline, ciprofloxacin, gentamicin and amikacin was tested for all isolates using a standard discdiffusion method on Mueller-Hinton agar plates (Oxoid) and using breakpoints defined by the Clinical and Laboratory Standards Institute (CLSI). All of the study isolates were evaluated for production of ESBLs according to the CLSI criteria (CLSI, 2010) . Antimicrobial discs containing ceftazidime/clavulanic acid and cefotaxime/clavulanic acid were used for this purpose. E. coli ATCC 25922 was used as the quality-control strain.
The MICs of ampicillin, cefotaxime, cefotaxime+clavulanic acid (fixed concentration of 4 mg ml 21 ), ceftazidime, ceftazidime+clavulanic acid (fixed concentration of 4 mg ml 21 ) and aztreonam were determined for the bla CTX-M-22/69 -producing clinical isolates, the transconjugants and the PCR clones using CLSI methodology (CLSI, 2010) . Detection of b-lactamase genes. PCR analyses were performed to identify various b-lactamase genes in all ESBL-producing isolates. The genes investigated included bla TEM , bla SHV and bla CTX-M (including bla CTX-M-1 , bla CTX-M-2 and bla CTX-M-9 groups) (de Oliveira Garcia et al., 2008) . In addition, PCR experiments were also performed to amplify the bla CMY-2 and bla KPC genes for isolates that were ESBLnegative but non-susceptible to cephalosporin or imipenem, as described previously (Yan et al., 2004; Yigit et al., 2001) . PCR products were sequenced on both strands using an ABI Prism 3730 Genetic Analyzer (Applied Biosystems). PFGE. PFGE was performed for 59 bla CMY-2 -producing isolates from humans and swine to assess the overlap in the two group ecosystems. Chromosomal DNA was prepared as described previously (Matushek et al., 1996) and digested with XbaI restriction enzyme. Electrophoresis was performed using a CHEF DRIII System (Bio-Rad). The electrophoresis conditions included a 22 h run time with a 120u angle and at 6.0 V cm 21 and a temperature of 15 uC. The results were analysed by following the criteria established by Tenover et al. (1995) .
Transfer and phenotype of CTX-M-69. Conjugation experiments for the CTX-M-69-producing isolates were performed using an azideresistant mutant of E. coli DH5a as the recipient. Transconjugants were selected on tryptic soy agar containing sodium azide (50 mg ml 21 ) and cefotaxime (2 mg ml 21 ). To assess whether the amino acid substitutions observed in CTX-M-69 affected the level of resistance to b-lactams, E. coli clones producing CTX-M-69 and its putative progenitor CTX-M-22 (GenBank accession no. EU376964) were constructed. The structural genes corresponding to the enzymes were amplified with primers CTXM-1-F-BamHI (59-CGGGATCCGA-TGGTTAAAAAATCA-39) and CTXM-1-R-HindIII (59-GCCAAGCT-TTTACAAACCGTTGGTG-39) (underlining indicates the BamHI and HindIII restriction sites, respectively). Purified PCR products were ligated with pET30b(+) (Novagen). E. coli BL21(DE3) (Novagen) was then transformed using these recombinant plasmids.
Statistical analysis. Fisher's exact test and a x 2 test were used as appropriate to compare the susceptibility testing results of the human and swine isolates.
RESULTS AND DISCUSSION
Antibiotic susceptibility testing A total of 447 E. coli isolates (280 human and 167 swine isolates) were investigated in this study. Non-susceptibility to third-or fourth-generation cephalosporins (ceftazidime, ceftriaxone, cefotaxime, cefpodoxime, ceftiofur and cefepime) and aztreonam was significantly more common in the human than in the swine isolates (Table 2) . Resistance to third-or fourth-generation cephalosporins ranged from 22.1 to 46.8 % in humans and from 0 to 9.6 % in swine. No difference in resistance to antimicrobials was observed between volunteers and patients, or among pig farms (P.0.05). Of note, 5.4 % of the isolates from humans but none from swine were non-susceptible to imipenem (Table 2) . Among the swine isolates, 24.6 % were nonsusceptible to ceftiofur. This represents a substantial increase in ceftiofur resistance compared with a previous study conducted in China in 2000, which showed all isolates from animals to be susceptible to this agent (Yang et al., 2004) .
The reason for this increase may be that ceftiofur was approved for use in animals in China in 2002 (Zhou et al., 2000) , with its use in these settings potentially leading to the selection of resistant strains (Carattoli et al., 2002) . Resistance to ceftiofur correlates with decreased susceptibility to other extended-spectrum cephalosporins, including ceftriaxone, which is an agent commonly used for the treatment of infections in humans (M'ikanatha et al., 2010) .
Variable degrees of resistance to non-b-lactam antimicrobials were observed. Most isolates from humans (92.9 %) and swine (92.8 %) were non-susceptible to tetracycline. Alarmingly, the majority of isolates were also resistant to ciprofloxacin (76.8 % of the human isolates and 86.2 % of the swine isolates). The reason for this high rate of ciprofloxacin resistance among swine isolates may be that fluoroquinolones are often used on swine farms in China (Tian et al., 2009) . Amikacin and gentamicin resistance were detected in 20.0 and 25.4 % of the isolates from humans, and in 7.2 and 52.7 % of the isolates from swine, respectively (Table 2) .
Of the 447 isolates tested, 120 isolates (26.8 %) were confirmed as ESBL-producers. The prevalence of ESBLproducing isolates was significantly higher for isolates of human origin than for those of swine origin (39.3 vs 6.0 %; P,0.001). However, the prevalence among human isolates was much lower than that reported in human clinical isolates over a similar time period in China (87.8 %; Yu et al., 2007) . This lower prevalence may be due to less intense selective pressure affecting commensal organisms than clinically significant isolates. Isolates from five out of seven pig farms were observed to produce ESBLs. These ESBL-producing isolates were associated with resistance to broad-spectrum b-lactams including ceftazidime, cefotaxime and aztreonam. It should also be noted that, as we only included one isolate from each volunteer or pig, regardless of susceptibility, the actual rates of carriage of ESBLproducing E. coli among these subjects may be much higher.
Detection of b-lactamase genes
The genes for clinically important b-lactamases (ESBL, CMY and KPC) identified in the study isolates are summarized in Table 3 . Complete ESBL gene sequences were available for 120 of the 127 ESBL-producing isolates. Among these, 70 and 40 human isolates carried a member of the bla CTX-M-1 group (13 bla CTX-M-3 , 21 bla CTX-M-15 , four bla CTX-M-22 , eight bla CTX-M-28 , four bla CTX-M-36 , 15 bla CTX-M-55 and five bla CTX-M-69 ) or bla SHV (14 bla SHV-2 , seven bla SHV-5 , ten bla SHV-12 , five bla SHV-57 and four bla SHV-97 ), respectively. Six and four swine isolates carried a member of the bla CTX-M-1 group (one bla CTX-M-15 and five bla CTX-M-22 ) or bla SHV (three bla SHV-2 and one bla SHV-12 ), respectively. All ESBL types found among the swine isolates were also detected among the human isolates. In the human isolates, no or little difference in carriage rates or types of b-lactamases was observed between volunteers and patients, or among hospitals (P.0.05). No isolate harboured more than one ESBL gene. All isolates carried bla TEM-1 , whereas none carried the bla CTX-M-2/9 group. The ESBL types observed in swine were similar to those in a previous study in the same region (Tian et al., 2009 ) but totally different from the results of a study in southern China, where bla CTX-M-14 and bla CTX-M-27 were the predominant ESBLs (Liu et al., 2007) .
A novel CTX-M-1-group ESBL gene was identified in five human isolates and designated bla CTX-M-69 , with 8 and 2 aa substitutions compared with CTX-M-1 and CTX-M-22, respectively, the latter being the closest known b-lactamase of CTX-M-69 with A77V and D240G substitutions. Furthermore, to the best of our knowledge, this is the first time that bla SHV-57 and bla have been detected in China. The diversity of the ESBLs observed in this study probably represents a combination of factors, including an ongoing spread and exchange of the ESBL genes between and within humans and animals, and continuous evolutionary pressure arising from antimicrobial use in the respective environments.
Additionally, the bla CMY-2 gene was detected in 52 human and seven swine isolates. These cephalosporin-resistant isolates were negative for ESBL production except for two human isolates that carried bla CTX-M-69 . Seven imipenemnon-susceptible human isolates were positive for bla KPC-2 . CMY-2 is the most common plasmid-borne AmpC blactamase in E. coli, in both human and animal isolates. In animals, however, it is found primarily in poultry (Liu et al., 2007) . To our knowledge, this is the first time that CMY-2 has been reported from swine in China. A KPCtype b-lactamase has been reported previously from human E. coli isolates in several studies from China (Cai et al., 2008; Li et al., 2010) . However, our finding is significant in that it was found in E. coli isolated from healthy volunteers, who were mostly health-care workers recruited in hospitals. Future studies are needed to evaluate potential dissemination of bla KPC-2 into the community, which has profound public health implications.
PFGE
No or few clonal relationships were detected among the CMY-2-producing isolates (data not shown). These results suggested that the role of clonal transmission via patientto-patient, animal-to-animal or animal-to-human routes may be limited in the spread of bla CMY-2 -producing E. coli.
Transfer and phenotype of the bla CTX-M-69 gene
All five isolates carrying the bla CTX-M-69 gene yielded transconjugants that were positive for this gene. The MICs for the transconjugants were similar to those for the parental isolates (Table 4 ). They demonstrated high-level cefotaxime and ceftazidime resistance (MICs .64 mg ml 21 ), which represented a ¢256-fold increase over the MICs for the recipient strain (Table 4 ). These results suggested location of the bla CTX-M-69 gene on selftransmissible plasmids and their contribution to high-level cefotaxime and ceftazidime resistance in E. coli. (Table 4 ). Both PCR clones displayed susceptibility patterns typical for organisms producing CTX-M-type enzymes, with higher levels of resistance to cefotaxime than to ceftazidime. These results suggested that the kinetic properties of CTX-M-69 were probably not altered by the substitutions compared with its progenitor, CTX-M-22.
Conclusion
The prevalence of resistance to antimicrobials was much lower in swine for almost all compounds tested, except for ampicillin, gentamicin and ciprofloxacin. This may reflect the widespread use of these compounds in human and veterinary medicine. The rates of carriage of broadspectrum b-lactamases among commensal E. coli isolates were lower in swine than in humans, suggesting that blactamase genes have not established themselves in animal ecosystems in western China at the current time. 
